These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18424481)

  • 21. Bilateral horizontal gaze palsy in benign multiple sclerosis.
    Martinovic V; Nikolic I; Mesaros S; Drulovic J
    Acta Neurol Belg; 2020 Apr; 120(2):473-474. PubMed ID: 30560418
    [No Abstract]   [Full Text] [Related]  

  • 22. Orbicularis oculi reflex abnormalities in patients with multiple sclerosis: a clinical, EMG, and MRI investigation.
    Klissurski M; Novachkova S; Tzvetanov P; Alexiev F
    Electromyogr Clin Neurophysiol; 2009; 49(1):59-63. PubMed ID: 19280801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways.
    Sepulcre J; Masdeu JC; Goñi J; Arrondo G; Vélez de Mendizábal N; Bejarano B; Villoslada P
    Mult Scler; 2009 Mar; 15(3):337-44. PubMed ID: 18987107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
    Piskulić D; Olver JS; Maruff P; Norman TR
    Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
    Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.
    Cohen JA; Imrey PB; Calabresi PA; Edwards KR; Eickenhorst T; Felton WL; Fisher E; Fox RJ; Goodman AD; Hara-Cleaver C; Hutton GJ; Mandell BF; Scott TF; Zhang H; Apperson-Hansen C; Beck GJ; Houghtaling PL; Karafa MT; Stadtler M;
    Neurology; 2009 Feb; 72(6):535-41. PubMed ID: 19204263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
    Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
    Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels.
    Giacomini PS; Levesque IR; Ribeiro L; Narayanan S; Francis SJ; Pike GB; Arnold DL
    Arch Neurol; 2009 Mar; 66(3):375-81. PubMed ID: 19273757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging as a surrogate for treatment effect on multiple sclerosis relapses.
    Arnold DL; Goodin DS
    Ann Neurol; 2009 Mar; 65(3):237-8. PubMed ID: 19334057
    [No Abstract]   [Full Text] [Related]  

  • 30. Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting.
    Eissa A; Lebel RM; Korzan JR; Zavodni AE; Warren KG; Catz I; Emery DJ; Wilman AH
    J Magn Reson Imaging; 2009 Oct; 30(4):737-42. PubMed ID: 19787716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemicontracture and facial myokimia as the first manifestation of multiple sclerosis].
    Dupeyron A; Chaury F; Guiraud-Chaumeil C; Tranchant C
    Rev Neurol (Paris); 2001 Mar; 157(3):315-7. PubMed ID: 11319495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Onset of multiple sclerosis following post-partum depressive and manic episodes.
    Akkaya C; Kocagoz SZ; Turan OF; Taskapilioglu O; Kirli S
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):698-9. PubMed ID: 18081637
    [No Abstract]   [Full Text] [Related]  

  • 33. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Birnbaum G; Cree B; Altafullah I; Zinser M; Reder AT
    Neurology; 2008 Oct; 71(18):1390-5. PubMed ID: 18525027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.
    Frohman EM; Dwyer MG; Frohman T; Cox JL; Salter A; Greenberg BM; Hussein S; Conger A; Calabresi P; Balcer LJ; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):96-105. PubMed ID: 19439327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
    Portaccio E; Zipoli V; Goretti B; De Stefano N; Amato MP
    Mult Scler; 2009 Mar; 15(3):403; author reply 404. PubMed ID: 19244397
    [No Abstract]   [Full Text] [Related]  

  • 36. A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis.
    Kaiser CC; Shukla DK; Stebbins GT; Skias DD; Jeffery DR; Stefoski D; Katsamakis G; Feinstein DL
    J Neuroimmunol; 2009 Jun; 211(1-2):124-30. PubMed ID: 19446890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
    Calabrese M; Filippi M; Rovaris M; Bernardi V; Atzori M; Mattisi I; Favaretto A; Grossi P; Barachino L; Rinaldi L; Romualdi C; Perini P; Gallo P
    Mult Scler; 2009 Jan; 15(1):36-41. PubMed ID: 18755823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular flutter associated with a localized lesion in the paramedian pontine reticular formation.
    Schon F; Hodgson TL; Mort D; Kennard C
    Ann Neurol; 2001 Sep; 50(3):413-6. PubMed ID: 11558800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadolinium-enhancing or active T2 magnetic resonance imaging lesions in multiple sclerosis clinical trials?
    Bonzano L; Roccatagliata L; Mancardi GL; Sormani MP
    Mult Scler; 2009 Sep; 15(9):1043-7. PubMed ID: 19570818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.